Amgen Tour of California | World Leader Marianne Vos Wins Women’s Stage 3
The 97 women competing in the Amgen Breakaway from Heart Disease™ Women’s Race Empowered with SRAM also spent the day in Santa Rosa contesting a 64-mile twisting course that concluded with three lightening-fast circuits downtown that were lined with fans.
Stage 3 (of four), saw lots of early attacks that were foiled before a break could get away. Not until the second Queen of the Mountain (QOM) climb of the day on Coleman Valley Road did Wiggle High5’s Mara Abbott (Boulder, Colo.) and Boels-Dolmans Cycling Team’s Evelyn Stevens (Claremont, Calif.) get clear from the peloton. Abbott, the first U.S. cyclist to win the Giro Donne (2010), one of the women’s Grand Tours, quickly took a solo lead, with Stevens, the new women’s hour record holder, falling back into a chase group of seven that also included her teammate and race leader Megan Guarnier (Glens Falls, New York); four-time National Time Trial Champion and two-time Olympic gold medalist Kristin Armstrong (Memphis, Tenn.) of TWENTY16 – Ridebiker; Katie Hall (Oakland, Calif.) of UnitedHealthcare Professional Cycling Team; UCI’s number-one-ranked rider Emma Johansson (SWE) of Wiggle High5 Pro Cycling; Alena Amialiusik (BLR) of Canyon/SRAM Racing and Eri Yonamine (JPN) of Hagens Berman | Supermint Pro Cycling Team. The group caught Abbott with about 20 miles left to ride, and the former National Champion fell back to the main bunch, but not before shoring up the Lexus Queen of the Mountain (QOM) and Breakaway from Cancer® Most Courageous Rider jerseys.
“Mara attacked on the second climb… There was a small group that let Boels-Dolmans chase, so it was on me and Evie [Evelyn Stevens] to bring that back. I’m a little bit surprised it came back because it was a pretty good breakaway,” said Guarnier, the Boels-Dolmans race leader and National Champion.
The rest of the chase group soon was reabsorbed as well, with a main group of 25 barreling together together toward the downtown circuits in the hunt for a sprint finish. Attacks came hard and aplenty on the circuits, with UnitedHealthcare’s Linda Villumsen (NZL) riding up front and shutting them down. Bay area cyclist Ruth Winder for USA Cycling and 19 year-old Chloe Dygert (Bremerton, Wash.) of TWENTY16 – Ridebiker took short-lived leads, much to the excitement of the roaring crowds.
Coming into the final turn, TWENTY16 – Ridebiker and UnitedHealthcare Pro Cycling took over at the front to lead out their sprinters, but experience trumped all else today with cycling’s winningest woman of all time, Rabo-Liv Women Cycling Team’s Marianne Vos (NED) rocketing out from the pack to take the win. She was followed over the line by UnitedHealthcare’s Coryn Rivera and Johansson of Wiggle High5. A star of the junior circuit, Rivera has won 70 national titles, including her first elite level title as 2014 National Criterium Champion.
Reigning U.S. National Road Race Champion and current race leader Megan Guarnier, increased her lead with bonus points earned at the one Sprint point at Carmet Beach today, also earning her the Visit California Sprint Jersey. The SRAM Best Young Rider Jersey remains with 19 year-oldChloe Dygert (Bremerton, Wash.).
Vos’ win today puts her into the top-5 in the overall standings with one day left to ride. Guarnier held onto the Amgen Race Leader Jersey and gained three seconds on Armstrong (TWENTY16 – Ridebiker) (+:15”), with Stevens remaining in third place (+:25”), and Voss moving up from seventh to fourth (+:43”), just besting Rivera at (+:44”).
The four-stage, 197.8-mile road race, the first of only two U.S. events on the first-ever UCI Women’s WorldTour, will conclude tomorrow, along with the men’s event, with a 41-mile circuit race (20 laps) around Capitol Park in Sacramento.
Stage 3 Podium
Stage 3 Jersey Winners
Celebrating its 11th year, the Amgen Tour of California is the most esteemed stage race in the U.S. Amgen has been the title sponsor of the race since its first year.
As part of Amgen’s effort to honor and celebrate cancer survivors and to raise awareness of its Breakaway from Cancer® initiative, a Breakaway Mile walk took place today as part of Santa Rosa’s annual Luther Burbank Rose Parade. Led by one of America’s most recognized journalists, cancer survivor and advocate Joan Lunden served as Grand Marshal of the parade and was joined by 200 community members at the front of the parade to honor the millions of cancer survivors millions worldwide.
During Lunden’s battle with cancer she committed herself to being an advocate for those battling cancer. Through her work, she inspired others to protect their own health. Lunden opened up to the public about her personal journey with the hopes that she could offer support and inspiration and provide a better understanding of the cancer treatment process.
“What an honor to be part of Amgen’s Breakaway from Cancer and the Luther Burbank Rose Parade to help bring awareness to the resources available to those impacted by cancer,” said Lunden. “It was exhilarating to lead the parade and honor and celebrate cancer survivors and their families. The excitement in downtown Santa Rosa was remarkable!”
For more information about Breakaway from Cancer, visit breakawayfromcancer.com.
Amgen created Breakaway from Heart Disease™ as a complementary component to the Amgen Tour of California. The collective goal of the campaign is to fundamentally change the future of America’s heart health by helping people to find out more about their family’s history of heart disease and encouraging them to get active through cycling. For more information, visit breakawayfromheartdisease.com
RACE CONCLUSION TOMORROW: MEN’S STAGE 8 & WOMEN’S STAGE 4, PRESENTED BY LEXUS
Sat., May 20 – Santa Rosa
Race fans can catch the May 22 conclusion live on NBC, follow along on the Microsoft Tour Tracker App for mobile and desktop, and connect with the race through all of their favorite social media platforms. Links are available at the Social drop-down menu at www.amgentourofcalifornia.com and fans can use #AMERICASGREATESTRACE to join the conversation.
About the Amgen Tour of California and the Amgen Breakaway from Heart Disease Women’s Race Empowered with SRAM
The Amgen Tour of California is listed on the international professional cycling calendar (2 HC, meaning “beyond category”), awarding important, world-ranking points to the top finishers. This year, the course will cover 782 miles over eight days through 12 host cities, including San Diego (first-time host), South Pasadena (first-time host), Santa Clarita, Thousand Oaks, Santa Barbara County, Morro Bay (first-time host), Monterey County, Lodi, South Lake Tahoe (first-time host), Folsom, Santa Rosa and Sacramento.
The Amgen Breakaway from Heart Disease Women’s Race Empowered with SRAM will run for the latter half of the men’s race (May 19-22) as the U.S. debut event on the inaugural UCI Women’s WorldTour (WWT).
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
(c)2016 AEG | SCVTV